Market Research Logo

North America Companion Diagnostics Market Forecast 2018-2026

North America Companion Diagnostics Market Forecast 2018-2026
KEY FINDINGS

The North America companion diagnostics market is projected to rise with a CAGR of 18.62% over the forecast period of 2018-2026. Initiatives to promote precision medicine research along with the strategic alliances between key market players for companion diagnostics test development are factors that are responsible for propelling the market growth.

MARKET INSIGHTS

Major revenue contribution comes from the US companion diagnostics market for this region. The US government has initiated “The Precision Medicine Initiative”, with an aim to treat diseases and improve health by funding the research for precision medicines. In Canada, the growing prevalence of cancer is a major concern and is responsible for the increased market demand for precision medicines. Also, government investments to enhance drug discovery and development activities across Canada are expected to create lucrative growth opportunities for the companion diagnostics market.

COMPETITIVE INSIGHTS

Some of the leading market companies in this region are Abbott Laboratories, Thermo Fisher Scientific Inc, Myriad Genetics Inc, Roche Diagnostics (A Hoffmann-La Roche Ag Divison), Qiagen N.V, Danaher Corporation, Illumina Inc, Biocartis, Ge Healthcare, Sysmex Corporation, Almac Group, Genomic Health and Biomerieux S.A.


1. Research Scope
1.1. Study Goals
1.2. Scope Of The Market Study
1.3. Who Will Find This Report Useful?
1.4. Study And Forecasting Years
2. Research Methodology
2.1. Sources Of Data
2.1.1. Secondary Data
2.1.2. Primary Data
2.2. Top Down Approach
2.3. Bottom-up Approach
2.4. Data Triangulation
3. Executive Summary
3.1. Market Summary
3.2. Key Findings
3.2.1. Oncology Market To Hold The Largest Market Share In Terms Of Indicator
3.2.2. Assay Kits And Reagents Are Significantly Used In Terms Of Products And Services
3.2.3. Increasing Cancer Incidence In North America
3.2.4. Next Generation Sequencing Is Growing Significantly
4. Market Determinants
4.1. Market Drivers
4.1.1. Rising Demand For Targeted Therapy
4.1.2. Increasing Prevalence Of Cancer
4.1.3. Swelling Strategic Initiatives For Companion Diagnostics Test Development
4.2. Market Restraints
4.2.1. Issues Related To Intellectual Property Rights
4.2.2. Reimbursement Issues
4.3. Market Opportunity
4.3.1. Focused On Implementing Companion Diagnostics Due To Rising New Indication Areas
4.3.2. Growing Demand For Next-generation Sequencing
4.3.3. Escalating Number Of Clinical Trials In Companion Diagnostics
4.4. Market Challenges
4.4.1. Prolonged Development Time Of Companion Diagnostics
4.4.2. Lengthy Approval Process
5. Market Segmentation
5.1. Market By Products And Services 2018-2026
5.1.1. Assay Kits And Reagents
5.1.2. Software And Service
5.2. Market By Indication 2018-2026
5.2.1. Oncology
5.2.2. Neurology
5.2.3. Infectious Diseases
5.2.4. Other Indications
5.3. Market By End User 2018-2026
5.3.1. Pharmaceutical And Biopharmaceutical Companies
5.3.2. Reference Laboratories
5.3.3. Other End Users
5.4. Market By Technology 2018-2026
5.4.1. In Situ Hybridization
5.4.2. Polymerase Chain Reaction
5.4.3. Immunohistochemistry
5.4.4. Next Generation Sequencing
5.4.5. Other Technologies
6. Key Analytics
6.1. Porter’s 5 Forces Analysis
6.1.1. Threat Of New Entrants
6.1.2. Threat Of Substitute Products
6.1.3. Bargaining Power Of Buyer
6.1.4. Bargaining Power Of Supplier
6.1.5. Intensity Of Competitive Rivalry
6.2. Etymology Of Companion Diagnostics
6.3. Supply Chain Analysis
6.4. Key Buying Criteria
6.5. Regulatory Framework
6.6. Estimation Analysis
7. Geographical Analysis
7.1. North America
7.1.1. The United States
7.1.2. Canada
8. Company Profiles
8.1. Competitive Landscape
8.2. Abbott Laboratories.
8.2.1. Company Overview
8.2.2. Product Portfolio
8.2.3. Scot Analysis
8.2.4. Strategic Initiatives
8.3. Almac Group
8.3.1. Company Overview
8.3.2. Product Portfolio
8.3.3. Scot Analysis
8.3.4. Strategic Initiatives
8.4. Arup Laboratories
8.4.1. Company Overview
8.4.2. Product Portfolio
8.4.3. Scot Analysis
8.5. Biocartis
8.5.1. Company Overview
8.5.2. Product Portfolio
8.5.3. Scot Analysis
8.5.4. Strategic Initiatives
8.6. Biomerieux S.A
8.6.1. Company Overview
8.6.2. Product Portfolio
8.6.3. Scot Analysis
8.7. Danaher Corporation
8.7.1. Company Overview
8.7.2. Product Portfolio
8.7.3. Scot Analysis
8.7.4. Strategic Initiatives
8.8. Ge Healthcare
8.8.1. Company Overview
8.8.2. Products Portfolio
8.8.3. Scot Analysis
8.8.4. Strategic Initiatives
8.9. Genomic Health
8.9.1. Company Overview
8.9.2. Product Portfolio
8.9.3. Scot Analysis
8.9.4. Strategic Initiatives
8.10. Illumina, Inc.
8.10.1. Company Overview
8.10.2. Product Portfolio
8.10.3. Scot Analysis
8.10.4. Strategic Initiatives
8.11. Myriad Genetics, Inc.
8.11.1. Company Overview
8.11.2. Product Portfolio
8.11.3. Scot Analysis
8.11.4. Strategic Initiatives
8.12. Qiagen N.V.
8.12.1. Company Overview
8.12.2. Product Portfolio
8.12.3. Scot Analysis
8.12.4. Strategic Initiatives
8.13. Roche Diagnostics (A Hoffmann-la Roche Ag Divison)
8.13.1. Company Overview
8.13.2. Product Portfolio
8.13.3. Scot Analysis
8.13.4. Strategic Initiatives
8.14. Sysmex Corporation
8.14.1. Company Overview
8.14.2. Product Portfolio
8.14.3. Scot Analysis
8.14.4. Strategic Initiatives
8.15. Thermo Fisher Scientific, Inc.
8.15.1. Company Overview
8.15.2. Product Portfolio
8.15.3. Scot Analysis
8.15.4. Strategic Initiatives
Table List
Table 1 North America Companion Diagnostics Market 2018-2026 ($ Million)
Table 2 Personalized Therapeutics Approved By The Fda
Table 3 North America Companion Diagnostics Market By Product And Service 2018-2026 ($ Million)
Table 4 North America Companion Diagnostics Market In Assay Kits And Reagents 2018-2026 ($ Million)
Table 5 North America Companion Diagnostics Market In Software And Service 2018-2026 ($ Million)
Table 6 North America Companion Diagnostics Market By Indication 2018-2026 ($ Million)
Table 7 North America Companion Diagnostics Market In Oncology 2018-2026 ($ Million)
Table 8 North America Companion Diagnostics Market In Neurology 2018-2026 ($ Million)
Table 9 North America Companion Diagnostics Market In Infectious Diseases 2018-2026 ($ Million)
Table 10 North America Companion Diagnostics Market In Other Indications 2018-2026 ($ Million)
Table 11 North America Companion Diagnostics Market By End User 2018-2026 ($ Million)
Table 12 North America Companion Diagnostics Market In Pharmaceutical And Biopharmaceutical Companies 2018-2026 ($ Million)
Table 13 North America Companion Diagnostics Market In Reference Laboratories 2018-2026 ($ Million)
Table 14 North America Companion Diagnostics Market In Other End Users 2018-2026 ($ Million)
Table 15 North America Companion Diagnostics Market By Technology 2018-2026 ($ Million)
Table 16 North America Companion Diagnostics Market In In Situ Hybridization 2018-2026 ($ Million)
Table 17 North America Companion Diagnostics Market In Polymerase Chain Reaction 2018-2026 ($ Million)
Table 18 North America Companion Diagnostics Market In Immunohistochemistry 2018-2026 ($ Million)
Table 19 North America Companion Diagnostics Market In Next Generation Sequencing 2018-2026 ($ Million)
Table 20 North America Companion Diagnostics Market In Other Technologies 2018-2026 ($ Million)
Table 21 North America Companion Diagnostics Market By Countries 2018-2026 ($ Million)
Table 22 The United States Companion Diagnostics Market By Indication 2018-2026 ($ Million)
Table 23 Canada Companion Diagnostics Market By Indication 2018-2026 ($ Million)
Figures List
Figure 1 North America Companion Diagnostics Market 2018-2026 ($ Million)
Figure 2 Growing Number Of People With Cancer Worldwide
Figure 3 Supply Chain Analysis Of Companion Diagnostics Industry
Figure 4 Key Buying Criteria
Figure 5 Newly Registered Clinical Trial Study 2016-2018
Figure 6 The United States Companion Diagnostics Market 2018-2026 ($ Million)
Figure 7 Canada Companion Diagnostics Market 2018-2026 ($ Million)
Figure 8 Company Market Share Of North America Companion Diagnostics Market 2017 (%)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report